中 / EN
2026-09-23 00:00 Clinical Launch & Registration Source language EN

Registry Marks BCI Stroke Study as Completed

Summary A study investigating brain-computer interface training combined with a lower-limb exoskeleton for walking difficulties after stroke is listed as completed. It compares conventional rehabilitation alone, rehabilitation plus exoskeleton training, and rehabilitation plus combined BCI and exoskeleton training. Each group has a target of 20 participants, not a confirmed actual enrollment figure. The primary assessment concerns lower-limb motor function; other measures cover EEG, balance, and walking ability. First enrollment was dated 2024-03-22, before registration on 2026-09-23, making registration non-prospective. The registry contains no results, so it does not establish whether combined training outperforms the other interventions.
Why it matters Eligibility requires a first stroke, disease duration of less than 6 months, and a Functional Ambulation Category score of 0–2. These population limits will matter when interpreting any subsequent results, rather than generalizing them to everyone with walking difficulties after stroke.

BCIwiki (bciwiki.com) — Study registration information concerning the Affiliated Hospital of Nantong University, China, lists trial ChiCTR2600133292, which combines a brain-computer interface with a lower-limb exoskeleton robot for walking dysfunction after stroke, as completed. The source record is a Chinese Clinical Trial Registry (ChiCTR) entry reproduced by the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP). It names the Affiliated Hospital of Nantong University as the primary sponsor.

The parallel-group interventional study was conducted in China. The control group receives conventional rehabilitation; the robot group adds lower-limb exoskeleton robot training to conventional rehabilitation; and the robot plus BCI group adds training that combines a brain-computer interface with a lower-limb exoskeleton robot. The registered target is 20 participants per group.

The study covers patients aged 18 to 80, of either sex, with walking dysfunction after stroke. Eligibility criteria include a first stroke, disease duration of less than 6 months, no serious cognitive impairment, stable clinical condition and vital signs, and a Functional Ambulation Category (FAC) score of 0–2. The primary outcome is the Fugl-Meyer Assessment-Lower Extremities (FMA-LE). Secondary outcomes are electroencephalogram (EEG), Berg Balance Scale (BBS), and Functional Ambulation Category.

The record gives 2024-03-22 as the first enrollment date and 2026-09-23 as the registration date, explicitly stating that registration was not prospective. It was last updated on 5 October 2026. Funding is listed as a self-selected, self-funded topic.

Compiled by BCIwiki from public sources

Sources · 1
Read original ↗
Suggest a correction Revisions · none 中 / EN
© 2026 BCIwiki.com Digest Topics Tips Subscribe Revisions About